Time of neuron origin in mouse hypothalamic nuclei.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMID 4743483)

Published in Exp Neurol on October 01, 1973

Authors

M Shimada, T Nakamura

Articles citing this

Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc Natl Acad Sci U S A (1989) 2.42

A genomic atlas of mouse hypothalamic development. Nat Neurosci (2010) 2.25

Pomc-expressing progenitors give rise to antagonistic neuronal populations in hypothalamic feeding circuits. Nat Med (2010) 1.88

Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice. Science (2011) 1.60

Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression. J Neurosci (2010) 1.32

Development, maturation, and necessity of transcription factors in the mouse suprachiasmatic nucleus. J Neurosci (2011) 1.30

Hypothalamic substrates of metabolic imprinting. Physiol Behav (2007) 1.25

Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons. Mol Cell Neurosci (2003) 1.21

Fgf10-expressing tanycytes add new neurons to the appetite/energy-balance regulating centers of the postnatal and adult hypothalamus. J Neurosci (2013) 1.17

Synaptogenesis of cultured striatal neurons in serum-free medium: a morphological and biochemical study. Proc Natl Acad Sci U S A (1986) 1.07

Critical periods for behavioral anomalies in mice. Environ Health Perspect (1976) 1.06

Presumptive common precursor for neuronal and glial cell lineages in mouse hypothalamus. Proc Natl Acad Sci U S A (1980) 1.06

Histogenesis of the supraoptic and paraventricular neurosecretory cells of the mouse hypothalamus. J Anat (1980) 1.03

Topography of Somatostatin Gene Expression Relative to Molecular Progenitor Domains during Ontogeny of the Mouse Hypothalamus. Front Neuroanat (2011) 0.98

Organizational actions of metabolic hormones. Front Neuroendocrinol (2013) 0.97

Roles for gamma-aminobutyric acid in the development of the paraventricular nucleus of the hypothalamus. J Comp Neurol (2010) 0.95

Development of the mouse suprachiasmatic nucleus: determination of time of cell origin and spatial arrangements within the nucleus. Brain Res (2007) 0.94

Rax is a selector gene for mediobasal hypothalamic cell types. J Neurosci (2013) 0.90

Genetic labeling of steroidogenic factor-1 (SF-1) neurons in mice reveals ventromedial nucleus of the hypothalamus (VMH) circuitry beginning at neurogenesis and development of a separate non-SF-1 neuronal cluster in the ventrolateral VMH. J Comp Neurol (2013) 0.89

The Notch effector gene Hes1 regulates migration of hypothalamic neurons, neuropeptide content and axon targeting to the pituitary. Dev Biol (2011) 0.86

The pathogenesis of abnormal cytoarchitecture in the cerebral cortex and hippocampus of the mouse treated transplacentally with cytosine arabinoside. Acta Neuropathol (1982) 0.86

Embryonic birthdate of hypothalamic leptin-activated neurons in mice. Endocrinology (2012) 0.85

Critical determinants of hypothalamic appetitive neuropeptide development and expression: species considerations. Front Neuroendocrinol (2009) 0.85

Notch/Rbpjκ signaling regulates progenitor maintenance and differentiation of hypothalamic arcuate neurons. Development (2013) 0.84

The LIM homeodomain factor Lhx2 is required for hypothalamic tanycyte specification and differentiation. J Neurosci (2014) 0.83

The non-evaginated secondary prosencephalon of vertebrates. Front Neuroanat (2011) 0.82

Embryonic development of circadian clocks in the mammalian suprachiasmatic nuclei. Front Neuroanat (2014) 0.81

Feed your head: neurodevelopmental control of feeding and metabolism. Annu Rev Physiol (2013) 0.81

Hypothalamic tanycytes-masters and servants of metabolic, neuroendocrine, and neurogenic functions. Front Neurosci (2015) 0.81

Notch signaling and proneural genes work together to control the neural building blocks for the initial scaffold in the hypothalamus. Front Neuroanat (2014) 0.80

Developmental specification of metabolic circuitry. Front Neuroendocrinol (2015) 0.79

Stage-specific inhibition of TrkB activity leads to long-lasting and sexually dimorphic effects on body weight and hypothalamic gene expression. PLoS One (2013) 0.77

Genetic manipulation of the mouse developing hypothalamus through in utero electroporation. J Vis Exp (2013) 0.77

Epigenomic and metabolic responses of hypothalamic POMC neurons to gestational nicotine exposure in adult offspring. Genome Med (2016) 0.76

Fgf10(+) progenitors give rise to the chick hypothalamus by rostral and caudal growth and differentiation. Development (2017) 0.76

Developmental influences on circuits programming susceptibility to obesity. Front Neuroendocrinol (2015) 0.76

Cell migration in the developing rodent olfactory system. Cell Mol Life Sci (2016) 0.76

Molecular and behavioral profiling of Dbx1-derived neurons in the arcuate, lateral and ventromedial hypothalamic nuclei. Neural Dev (2016) 0.76

LIM homeobox protein 5 (Lhx5) is essential for mamillary body development. Front Neuroanat (2015) 0.75

Rbpj-κ mediated Notch signaling plays a critical role in development of hypothalamic Kisspeptin neurons. Dev Biol (2015) 0.75

Mosaicism and cell proliferation patterns in the proliferative ventricular epithelium of the developing mouse embryo hypothalamus. Dokl Biol Sci (2007) 0.75

Articles by these authors

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25

CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature (1997) 10.49

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (2000) 6.96

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med (1996) 6.01

The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell (1992) 5.39

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation (2000) 5.36

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes (2001) 5.18

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell (1991) 4.98

A cyclic nucleotide-gated conductance in olfactory receptor cilia. Nature (1987) 4.81

STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J (1999) 4.55

Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg (1984) 4.45

Abdominal fat: standardized technique for measurement at CT. Radiology (1999) 4.25

Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med (1997) 4.06

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun (1984) 3.70

Immunochemical structure of hepatitis B e antigen in the serum. J Immunol (1983) 3.50

Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol (1999) 3.43

Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science (1998) 3.39

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1998) 3.23

Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet (1999) 3.19

Simultaneous inhibitions of inositol phospholipid breakdown, arachidonic acid release, and histamine secretion in mast cells by islet-activating protein, pertussis toxin. A possible involvement of the toxin-specific substrate in the Ca2+-mobilizing receptor-mediated biosignaling system. J Biol Chem (1985) 3.18

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16

The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res (1995) 3.04

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med (1996) 3.02

Yeast KEX2 genes encodes an endopeptidase homologous to subtilisin-like serine proteases. Biochem Biophys Res Commun (1988) 2.89

Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86

Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet (1999) 2.71

Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev (2000) 2.65

Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene. Science (2001) 2.61

An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res (2000) 2.59

Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Mol Cell Biol (1997) 2.57

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53

The Arabidopsis HKT1 gene homolog mediates inward Na(+) currents in xenopus laevis oocytes and Na(+) uptake in Saccharomyces cerevisiae. Plant Physiol (2000) 2.53

The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci U S A (1998) 2.52

Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med (1999) 2.51

A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology (1983) 2.49

A tumor promoter induces rapid and coordinated reorganization of actin and vinculin in cultured cells. J Cell Biol (1984) 2.46

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci (1999) 2.44

Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality. Oncogene (2001) 2.42

Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J (2000) 2.39

Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (1999) 2.38

Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A (1986) 2.37

Preparation of bioactive Ti and its alloys via simple chemical surface treatment. J Biomed Mater Res (1996) 2.34

Emerging multipotent aspects of hepatocyte growth factor. J Biochem (1996) 2.34

Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem (1978) 2.26

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet (1997) 2.20

Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest (2000) 2.18

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17

Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci U S A (1990) 2.15

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology (1993) 2.15

Functional brain networks in DYT1 dystonia. Ann Neurol (1998) 2.14

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut (1998) 2.11

Patterns of regional brain activation associated with different forms of motor learning. Brain Res (2000) 2.10

Bile leakage after hepatic resection. Ann Surg (2001) 2.08

Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res (1997) 2.06

Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg (1993) 2.06

Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science (1997) 2.06

p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J Biol Chem (1998) 2.05

Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology (1999) 2.03

Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03

Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. J Biochem (1978) 2.02

Staining for nerve fiber and cholinesterase activity in fresh frozen sections. Am J Clin Pathol (1967) 2.01

Contribution of serum ethanol concentration to the osmol gap: a prospective volunteer study. Clin Toxicol (Phila) (2013) 1.98

Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci (1995) 1.98

V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling. Nature (1998) 1.97

In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob Agents Chemother (1996) 1.97

Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97

Origin of the metallic properties of heavily boron-doped superconducting diamond. Nature (2005) 1.97

In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun (2000) 1.97

Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med (2000) 1.96

Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2. J Cell Biol (1999) 1.96

Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med (1987) 1.93

High sensitivity C-reactive protein in asthma. Eur Respir J (2006) 1.91

Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun (1985) 1.91

Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation (1999) 1.90

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest (2000) 1.90

A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res (1996) 1.90

Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res (1993) 1.89

Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases. Proc Natl Acad Sci U S A (1993) 1.89

Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene (1994) 1.89

Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis (1998) 1.88

Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res Treat (2001) 1.88

Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. J Biol Chem (2001) 1.86

Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem (1994) 1.84

A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc Res (2001) 1.84

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer (2009) 1.84

Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur J Immunol (1999) 1.82

Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 1.81

Mutations that alter the allosteric nature of cAMP receptor protein of Escherichia coli. EMBO J (1985) 1.80

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis. Osteoporos Int (2013) 1.79

Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun (1990) 1.79

Development of mast cells from grafted bone marrow cells in irradiated mice. Nature (1977) 1.78

NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J (2001) 1.78

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77

The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev (1987) 1.76

Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg (1997) 1.76